跳至主要内容
临床试验/NCT05784948
NCT05784948已完成不适用

Efficacy of Virtual Reality Mindfulness in Patients With Psychosis

Chonbuk National University Hospital2 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2020年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
67
试验地点
2
主要终点
Efficacy Assessment by Experience Questionnaire Decentering

研究概览

简要总结

This study is to evaluate the safety and efficacy of Virtual Reality Mindfulness in Patients With Psychosis.

详细描述

This study is randomized, single-blind and parallel group trial to evaluate the safety and the efficacy of Virtual Reality Mindfulness in Patients With Psychosis once a week over 8 weeks treatment period. Both groups can experience the screen coming out of the head-mounted display for 30 minutes in a comfortable sitting position.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
15 Years 至 59 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients who are 15-59 years (inclusive) of age at time of consent.
  • Patients with current DSM-5 (Diagnostic and Statistical Manual of Mental Disorders-fifth edition) diagnosis schizophrenia spectrum and other psychotic disorders including bipolar and related disorders or depressive disorder with psychotic symptoms.
  • Patients who can agree to participate in the study in a stable state (Clinical Global Impression score of 5 or less) and cooperate appropriately with questionnaires and tests.
  • Patients with a SOFAS score in the range of 41 to 80 points.
  • Patients with a PANSS score of less than 85 points.

排除标准

  • Patients who are currently in poor health due to serious physical illness
  • Patients who are currently pregnant or lactating.
  • Patients who are accompanying intellectual disability with an Intelligence Quotient (IQ) of 70 or lower
  • Patients who have difficulty in agreeing to and participating in research due to severely impaired ability to verify reality
  • Patients with a PANSS score of 85 or higher or a CGI of 6 or higher
  • Patients with a SOFAS score of 40 or less or 81 or more
  • Patients who are currently in hospitalized

结局指标

主要结局

Efficacy Assessment by Experience Questionnaire Decentering

时间窗: 1 week

The experience questionnaire (EQ) is a psychological measure used to assess attentional bias. The questionnaire consists of 15 items, with a minimum score of 1 and a maximum score of 7. The higher scores indicate the better outcome.

次要结局

  • Efficacy Assessment by Korea-Polyenvironmental Risk Score-I (PERS-I)(through study completion, an average of 8 weeks)
  • Efficacy Assessment by Columbia-Suicide Severity Rating Scale(1 week)
  • Efficacy Assessment by Health of the Nation Outcome Scales(1 week)
  • Safety Assessment by Skin conductance level(1 week)
  • Safety Assessment by Heart rate(1 week)
  • Efficacy Assessment by self rating scale Perceived Stress Scale (PSS)(1 week)
  • Efficacy Assessment by Korea-Polyenvironmental Risk Score-II (PERS-II)(through study completion, an average of 8 weeks)
  • Efficacy Assessment by Social and Occupational Functioning Assessment Scale(1 week)
  • Safety Assessment by R-R interval(1 week)
  • Efficacy Assessment by self rating scale Subjective Wellbeing under Neuroleptics(SWN-K)(1 week)
  • Efficacy Assessment by Positive and Negative Syndrome Scale(1 week)
  • Efficacy Assessment by self rating scale Motivation and Pleasure Scale-Self Report (MPS-SR)(1 week)
  • Efficacy Assessment by self rating scale Beck Depression Inventory (BDI)(1 week)
  • Efficacy Assessment by Psychotic Symptom Rating Scales (PSYRATS)(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Young Chul Chung

Professor of Psychiatry

Chonbuk National University Hospital

研究点 (2)

Loading locations...

相似试验